BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38110354)

  • 1. Inhibition of LRRK2 kinase activity rescues deficits in striatal dopamine physiology in VPS35 p.D620N knock-in mice.
    Bu M; Follett J; Deng I; Tatarnikov I; Wall S; Guenther D; Maczis M; Wimsatt G; Milnerwood A; Moehle MS; Khoshbouei H; Farrer MJ
    NPJ Parkinsons Dis; 2023 Dec; 9(1):167. PubMed ID: 38110354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
    Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
    Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endosomal traffic and glutamate synapse activity are increased in VPS35 D620N mutant knock-in mouse neurons, and resistant to LRRK2 kinase inhibition.
    Kadgien CA; Kamesh A; Milnerwood AJ
    Mol Brain; 2021 Sep; 14(1):143. PubMed ID: 34530877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered dopamine release and monoamine transporters in Vps35 p.D620N knock-in mice.
    Cataldi S; Follett J; Fox JD; Tatarnikov I; Kadgien C; Gustavsson EK; Khinda J; Milnerwood AJ; Farrer MJ
    NPJ Parkinsons Dis; 2018; 4():27. PubMed ID: 30155515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes.
    Wang X; Bondar VV; Davis OB; Maloney MT; Agam M; Chin MY; Cheuk-Nga Ho A; Ghosh R; Leto DE; Joy D; Calvert MEK; Lewcock JW; Di Paolo G; Thorne RG; Sweeney ZK; Henry AG
    Elife; 2023 Oct; 12():. PubMed ID: 37874617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous Rab29 does not impact basal or stimulated LRRK2 pathway activity.
    Kalogeropulou AF; Freemantle JB; Lis P; Vides EG; Polinski NK; Alessi DR
    Biochem J; 2020 Nov; 477(22):4397-4423. PubMed ID: 33135724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired neurogenesis in the hippocampus of an adult VPS35 mutant mouse model of Parkinson's disease through interaction with APP.
    Jiang M; Tu HT; Zhang K; Zhang W; Yu WP; Xu J; Tan EK; Guo KH; Zeng L
    Neurobiol Dis; 2021 Jun; 153():105313. PubMed ID: 33636388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered striatal dopamine levels in Parkinson's disease VPS35 D620N mutant transgenic aged mice.
    Vanan S; Zeng X; Chia SY; Varnäs K; Jiang M; Zhang K; Saw WT; Padmanabhan P; Yu WP; Zhou ZD; Halldin C; Gulyás B; Tan EK; Zeng L
    Mol Brain; 2020 Dec; 13(1):164. PubMed ID: 33261640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of
    Sargent D; Moore DJ
    Int Rev Mov Disord; 2021; 2():221-244. PubMed ID: 35497708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice.
    Ishizu N; Yui D; Hebisawa A; Aizawa H; Cui W; Fujita Y; Hashimoto K; Ajioka I; Mizusawa H; Yokota T; Watase K
    Hum Mol Genet; 2016 Oct; 25(20):4507-4517. PubMed ID: 28173004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Parkinson's disease related mutant VPS35 (D620N) amplifies the LRRK2 response to endolysosomal stress.
    McCarron KR; Elcocks H; Mortiboys H; Urbé S; Clague MJ
    Biochem J; 2024 Feb; 481(4):265-278. PubMed ID: 38299383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VPS35 D620N knockin mice recapitulate cardinal features of Parkinson's disease.
    Niu M; Zhao F; Bondelid K; Siedlak SL; Torres S; Fujioka H; Wang W; Liu J; Zhu X
    Aging Cell; 2021 May; 20(5):e13347. PubMed ID: 33745227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B.
    Pal P; Taylor M; Lam PY; Tonelli F; Hecht CA; Lis P; Nirujogi RS; Phung TK; Yeshaw WM; Jaimon E; Fasimoye R; Dickie EA; Wightman M; Macartney T; Pfeffer SR; Alessi DR
    Sci Adv; 2023 Dec; 9(50):eadj1205. PubMed ID: 38091401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant VPS35-D620N induces motor dysfunction and impairs DAT-mediated dopamine recycling pathway.
    Huang Y; Huang H; Zhou L; Li J; Chen X; Thomas J; He X; Guo W; Zeng Y; Low BC; Liang F; Zeng J; Ross CA; Tan EK; Smith W; Pei Z
    Hum Mol Genet; 2022 Nov; 31(22):3886-3896. PubMed ID: 35766879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VPS35 and retromer dysfunction in Parkinson's disease.
    Rowlands J; Moore DJ
    Philos Trans R Soc Lond B Biol Sci; 2024 Apr; 379(1899):20220384. PubMed ID: 38368930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease-linked
    Chen X; Kordich JK; Williams ET; Levine N; Cole-Strauss A; Marshall L; Labrie V; Ma J; Lipton JW; Moore DJ
    Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5765-5774. PubMed ID: 30842285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanisms.
    Malik AU; Karapetsas A; Nirujogi RS; Mathea S; Chatterjee D; Pal P; Lis P; Taylor M; Purlyte E; Gourlay R; Dorward M; Weidlich S; Toth R; Polinski NK; Knapp S; Tonelli F; Alessi DR
    Biochem J; 2021 Feb; 478(3):553-578. PubMed ID: 33459343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.
    Longo F; Mercatelli D; Novello S; Arcuri L; Brugnoli A; Vincenzi F; Russo I; Berti G; Mabrouk OS; Kennedy RT; Shimshek DR; Varani K; Bubacco L; Greggio E; Morari M
    Acta Neuropathol Commun; 2017 Mar; 5(1):22. PubMed ID: 28292328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes.
    Mercatelli D; Bolognesi P; Frassineti M; Pisanò CA; Longo F; Shimshek DR; Morari M
    Pharmacol Res Perspect; 2019 Jun; 7(3):e00484. PubMed ID: 31149340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson's disease mutant of Leucine-Rich Repeat Kinase 2 (LRRK2).
    Linhart R; Wong SA; Cao J; Tran M; Huynh A; Ardrey C; Park JM; Hsu C; Taha S; Peterson R; Shea S; Kurian J; Venderova K
    Mol Neurodegener; 2014 Jun; 9():23. PubMed ID: 24915984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.